Two cytokines IL-4 and IL-12 are known to determine the balance between T h 1 and T h 2 development. In addition to IL-4 production of V α 14 ⍣ NKT cells, they have recently been demonstrated to have the capacity to stimulate IL-12 production by antigen-presenting cells (APC). This study demonstrates that IFN-γ is absolutely required for the NKT cell-stimulated IL-12 production. Culture of B cell-depleted spleen cells from C57BL/6 mice with α-galactosylceramide (α-GalCer) capable of selectively stimulating V α 14/J α 281 ⍣ NKT
Introduction
The balance between T h 1 and T h 2 development is determined that this subset of NKT cells, particularly of CD4 ϩ NKT cells, has the capacity to stimulate IL-12 production by APC which by IL-4 and IL-12 (1) (2) (3) (4) (5) (6) . Therefore, the identification of the sources of these regulatory cytokines and the investigation they interact with (18). Thus, it appears that CD4 ϩ NKT cells are bipotential cells that may initiate both T h 2-and T h 1-type of regulatory mechanisms underlying the production of these cytokines would be important for understanding the two T h immune responses. IL-12 production is generally enhanced in the presence of differentiation processes. It has been speculated that effector cells involved in innate immunity play a pivotal role in shaping IFN-γ (19-21). Reciprocally, our previous study showed that IFN-γ is secreted by α-GalCer-stimulated CD4 ϩ NKT cells initial T cell activation (7) (8) (9) (10) . In this context, a population of T cells expressing NK1.1 and an almost invariant TCRαβ largely depending on IL-12 produced by interacting APC (18). Considering this positive feedback loop of IL-12 and (V α 14/J α 281) specific for CD1 (11) (12) (13) was shown to be capable of producing substantial amounts of IL-4 upon the IFN-γ production, this study investigated the role of IFN-γ in IL-12 production stimulated by α-GalCer-activated NKT cells. stimulation of their TCR (14) (15) (16) . In initial studies (14, 15) , this TCR stimulation leading to IL-4 production was performed
The results show that APC from IFN-γ -/-mice failed to produce IL-12 during interaction with α-GalCer-stimulated V α 14 ϩ NKT using anti-CD3 mAb. However, a recent study identified α-galactosylceramide (α-GalCer) as the ligand that stimulates cells. α-GalCer-activated NKT cells from wild-type and IFN-γ -/-mice induced comparable levels of IL-4 production, the V α 14/J α 281 TCR in association with CD1, and demonstrated CD1-restricted activation of V α 14 ϩ NKT cells and indicating that IL-4 production is predominant over IL-12 production in the absence of IFN-γ. These results suggest production of IL-4 following stimulation with α-GalCer (16 (100 ng/ml in 0.1% DMSO) or cultured with CD40L-expressing CHO cells (kindly provided by Dr H. Yagita, Juntendo University, Tokyo, Japan) in 24-well culture plates (Corning 25820;
Methods
Corning Glass Works, Corning, NY) in 1 ml of RPMI 1640 Mice medium supplemented with 10% FBS and 2-mercaptoethanol in a humidified atmosphere at 5% CO 2 at 37°C. Cells and C57BL/6(B6) mice were purchased from Shizuoka Laboratory culture SN were harvested and assessed for the expression Animal Center (Hamamatsu, Japan). IFN-γ-deficient (IFN-γ -/-) of CD40L or assayed for cytokine concentration. B6 mice (B6-Ifng tm1Ts ) (22) were obtained from Jackson Laboratories (Bar Harbor, MA). These mice were used at 6-9 weeks of age.
Antibody capture assay for IL-12 activity
The assay system was essentially the same as described by Reagents Gately and Chizzonite (28). Briefly, each well of 96-well KRN7000, a representative of synthetic α-GalCer, was premicroculture plates was coated with 10 µg of purified anti-ILpared in the Pharmaceutical Research Laboratory (Kirin 12 mAb (C15.1) (29). Culture SN or serum together with Brewery, Takasaki, Japan). In this paper, KRN7000 is standard mouse rIL-12 solution was incubated in wells of the described as α-GalCer. Mouse rIL-12 was provided by GenetmAb-coated plates. 
Preparation of various lymphoid populations
The IL-4 ELISA was constructed using anti-mouse IL-4 mAb [11B11 and biotinylated BVD4-1D11 (BVD4-1D11 mAb was B cell-depleted fraction. Spleen cells were depleted of B purified from the corresponding hybridoma and biotinylated cells by immunomagnetic negative selection as described in our laboratory)]. 11B11 and BVD4-1D11 hybridomas were (25, 26) . Briefly, spleen cells were incubated with magnetic obtained from ATCC. particles bound to goat anti-mouse Ig (Advanced Magnetic, Cambridge, MA). Surface Ig -cells (B cell-depleted fraction) were obtained by removing cells bound to the magnetic Detection of CD40L expression by flow cytometry particles with a rare earth magnet (Advanced Magnetic).
To detect the expression of CD40L on CD4 ϩ and CD4 -NK1.1 ϩ T cells, four-color flow cytometric analysis was per-DC-enriched population. Spleen cells were labeled with formed. Cells were first incubated with anti-FcγRIII/II mAb superparamagnetic microbeads conjugated to rat anti-mouse (2.4G2) to prevent the staining mAb from binding with the Fc CD11c mAb (Miltenyi Biotec, Sunnyvale, CA). Labeled cells receptors. These treated cells were then stained directly were separated from unlabeled cells by magnetic cell sorting with PE-conjugated anti-CD40L and biotinylated-anti-NK1.1 using the MiniMACS (Miltenyi Biotec) according to the procedfollowed by FITC-conjugated anti-TCRαβ, Red670-conjugated ure described in detail (27) . The magnetically labeled cells streptavidin and allophycocyanin-conjugated anti-CD4. The were retained in a MiniMACS column inserted into a MiniMACS stained cells were analyzed by FACSCalibur (Becton Dickinmagnet while the unlabeled cells passed through. Labeled son, Mountain View, CA). CD40L expression was detected by cells were eluted after the column was removed from the magnet and used as a DC-enriched population.
gating on a CD4 ϩ or CD4 -TCRαβ ϩ NK1.1 ϩ population. 
was an absolute requirement for IL-12 production induced by interaction between APC and α-GalCer-stimulated V α 14 ϩ NKT cells. expressed on the respective cell types (26, 31) . CD40L is induced after TCR triggering. This was the case with conventional CD4 ϩ T cells (26) and CD4 ϩ NKT cells (18), but not with conventional CD8 ϩ T cells (25) and CD4 -NKT cells (18).
Results
We compared the expression levels of CD40L on V α 14 ϩ α-GalCer stimulation of B cell-depleted splenocytes from wild-NKT cells from wild-type and IFN-γ -/-mice. B cell-depleted type B6 but not from IFN-γ -/-B6 mice induces IL-12 production splenocytes from wild-type and IFN-γ -/-mice were stimulated with anti-CD3 for 3 h, and then stained with anti-TCRαβ, antiEarlier studies demonstrated that stimulation of V α 14 ϩ NKT cells with α-GalCer plus APC results in the production of IL-4 NK1.1, anti-CD4 and anti-CD40L as described in Methods. The content of CD4 ϩ NKT cells in both groups of B cell-(16) and IL-12 (18). We examined whether IL-4 and IL-12 production is similarly induced in splenocytes from IFN-γ -/-depleted populations is shown in Fig. 3 (upper panels) , and the expression of CD40L on these cells is shown in comparison mice. The B cell-depleted splenic fractions were prepared from spleen cells of B6 (wild-type) and IFN-γ -/-B6 mice, and with CD4 -NKT cells and CD4 ϩ conventional (NK1.1 -) T cells (Fig. 3 , lower panels). CD40L expression was negative or stimulated with α-GalCer. Figure 1 shows that the level of IL-4 production is comparable in cultures from wild-type B6 and positive in CD4 -NKT cells or CD4 ϩ conventional T cells respectively, irrespective of whether the cells are from wild-IFN-γ -/-B6 splenocytes following α-GalCer stimulation, indicating that the activation of V α 14 ϩ NKT cells with α-GalCer type or IFN-γ -/-mice. CD40L was also detected on both wildtype and IFN-γ -/-CD4 ϩ NKT cells. The levels of CD40L occurs similarly irrespective of whether they have the IFN-γ-producing capacity. In contrast, IL-12 was produced in expression were comparable in wild-type and IFN-γ -/-CD4 ϩ NKT cells. cultures from wild-type splenocytes, whereas IFN-γ -/-splenocytes produced no IL-12 ( Fig. 2A) . Thus, the presence of IFN-γ
We have also compared CD40 expression between CD11c ϩ dendritic cell (DC) populations from wild-type and IFN-γ -/-spleen cells. A DC population consists of CD8 ϩ and CD8 -cells which differ in the cellular lineage and function (32-34). Therefore, DC-enriched populations were stained doubly with anti-CD11c and anti-CD8, and the levels of CD40 expression were examined in CD8 ϩ CD11c ϩ and CD8 -CD11c ϩ subsets. As shown in Fig. 4 , the levels of CD40 expression were comparable in these two subsets between wild-type and IFN-γ -/-mice. IL-12 is produced by CD11c ϩ DC as well as F4/80 ϩ macrophages. CD40 expression was also compared between F4/80 ϩ macrophage-enriched populations from wildtype and IFN-γ -/-splenocytes. The frequency of F4/80 ϩ macrophage in spleens as well as their CD40 expression depleted splenocytes were cultured with CD40L-expressing Six hours after α-GalCer injection, the mice were sacrificed and CHO cells (Fig. 2B) . APC from wild-type splenocytes proserum was individually harvested. The concentration of bioactive IL-12 (p70) was measured by an antibody capture assay and duced a large amount of IL-12. APC from IFN-γ -/-splenocytes expressed as the mean Ϯ SE.
exhibited apparently reduced albeit positive levels of IL-12 production. Together, the results indicate that there is no substantial difference between wild-type and IFN-γ -/-mice in the expression of CD40L and CD40 that are indispensable found to enhance IL-12 production by wild-type splenocytes stimulated with CD40L-expressing CHO cells (Fig. 5B) . This molecules for IL-12 production by T/NKT-APC interactions. The results also suggest that an alteration in CD40-mediated enhancement was also observed for IFN-γ -/-splenocytes and the levels of IFN-γ-enhanced IL-12 production were signaling may exist in IFN-γ -/-APC and such an alteration is more manifest when CD40L stimulation is weaker.
comparable. The effects of rIFN-γ on IL-12 p40 production by wild-type and IFN-γ -/-splenocytes were essentially the Restoration of IL-12 production in IFN-γ -/-splenocytes by same as those on IL-12 (p70) production (data not shown).
supplementing exogenous IFN-γ
Taken together, the results confirm that IFN-γ co-stimulation is more critical in IL-12 production stimulated by CD4 ϩ NKT We determined whether the failure of α-GalCer-stimulated IFN-γ -/-splenocytes to produce IL-12 can be corrected by cells than by CD40L-CHO cells. supplementing exogenous IFN-γ. rIFN-γ (10 ng/ml) was
Restoration of IL-12 production in IFN-γ -/-mice by adminisincluded in culture of IFN-γ -/-splenocytes stimulated with tering exogenous IFN-γ α-GalCer. As shown in Fig. 5(A) , addition of rIFN-γ to α-GalCer-stimulated culture of wild-type splenocytes did not We further examined whether there is a defect in IL-12 production in vivo in IFN-γ -/-mice when α-GalCer is injected enhance IL-12 production compared to that by these cells in the absence of rIFN-γ. In contrast, IL-12 production by IFNand, if so, whether IL-12 production is restored by administering rIFN-γ. As shown in Fig. 6(A) , IFN-γ -/-mice produced γ -/-splenocytes was restored by addition of rIFN-γ and the level of the restored IL-12 production was comparable to or negligible amounts of IL-12 following α-GalCer injection. However, this defect was almost completely corrected by slightly higher than that of wild-type splenocytes. rIFN-γ was simultaneous injection of rIFN-γ (Fig. 6B) . Together, these production in the CD40L-stimulation pathway involving the activation of V α 14 ϩ CD4 ϩ NKT cells instead of conventional results indicate that IFN-γ is an absolute requirement for IL-12 production induced by the participation of V α 14 ϩ NKT cells.
CD4 ϩ T cells. It is obvious that V α 14 ϩ CD4 ϩ NKT cells are activated with α-GalCer in IFN-γ -/-splenocyte cultures at similar degrees to those observed in wild-type cultures, Discussion because IL-4 production and CD40L expression were similarly induced in both types of cultures. Moreover, DC prepared Our earlier study demonstrated that stimulation of V α 14 ϩ CD4 ϩ NKT cells with α-GalCer plus splenic APC results in the from wild-type and IFN-γ -/-mice exhibited comparable levels of CD40 expression. Nevertheless, IL-12 production in IFN-γ -/-production of IL-12 along with IL-4. In conjunction with these observations, this study using IFN-γ -/-mice showed that IL-12 splenocyte cultures was at almost zero levels. IL-12 production of IFN-γ -/-DC/macrophages stimulated directly by CD40L-production induced in association with α-GalCer activation of these NKT cells depends on the presence of IFN-γ.
expressing CHO cells was also reduced compared to that of wild-type DC/macrophages, although it was not decreased IL-12 production by DC/macrophages is induced through two different pathways of stimulation: one that occurs when to zero level. Thus, IFN-γ deficiency alters IL-12 production in the T cell-dependent (CD40L stimulation) pathway. It should the cells were exposed to various pathogens or their products (35,36) and the other when DC/macrophages as APC interact be noted that such an alteration is much more evident in the process of IL-12 production involving V α 14 ϩ CD4 ϩ NKT cells with activated T cells (26, 31) . The latter pathway is mediated via molecular interactions between CD40 constitutively as a DC/macrophages-stimulating population. The consideration will be necessary regarding how IFN-γ expressed on DC/macrophages (APC) and CD40L that is induced on TCR-stimulated T cells (26, 31) . Thus, IL-12 is is required for the process of DC/macrophages IL-12 production in which V α 14 ϩ NKT cells participate. In this context, our produced by DC/macrophages through T cell-independent (bacterial stimulation) and T cell-dependent (CD40L stimulaprevious study (18) showed that IL-12 production in wild-type splenocyte cultures was not affected by addition of anti-IFN-γ tion) pathways. Initial studies concerned with the interaction between DC/macrophages and conventional T cells, and mAb. These observations suggested that IFN-γ is not required for IL-12 production in α-GalCer-stimulated cultures, which revealed that among these, only CD4 ϩ T cells can express CD40L upon activation and stimulate IL-12 production of DC/ appears to be not compatible with the present observations. However, our previous and present results regarding the macrophages (26) . Subsequently, this interaction was shown to be applied for the V α 14 ϩ CD4 ϩ NKT cell subpopulation requirement of IFN-γ may not necessarily be discordant. It is possible that DC/macrophages from wild-type mice have (18). Thus, two different subpopulations, V α 14 ϩ CD4 ϩ NKT cell and conventional CD4 ϩ T cell subpopulations, that function in already been exposed to endogenous IFN-γ before harvesting and rendered responsive to CD40-mediated signaling, innate and acquired immunity respectively are responsible for the stimulation of DC/macrophages for IL-12 production.
whereas DC/macrophages from IFN-γ -/-mice have not. Considering that DC themselves are capable of producing IFN-γ The production of a given cytokine is regulated by the cumulative effect of other cytokine signals (37) (38) (39) (40) (41) (42) . (49), it is likely that there exists a difference between wildtype and IFN-γ -/-DC in terms of whether they have acquired production has also been shown to be influenced by other cytokines such as IFN-γ and IL- 10 (19-21,35,36,43,44) . While responsiveness to CD40 stimulation in vivo. In this hypothesis, IL-12 production induced by the α-GalCer-initiated NKT-DC IL-12 stimulates IFN-γ production of NK/NKT and T cells (45, 46) , IFN-γ has the capacity to up-regulate IL-12 production interaction does not greatly differ between cultures of wildtype splenocytes with and without exogenous IFN-γ (Fig. 5 ) of DC/macrophages (19-21). However, this IFN-γ effect has been recognized mainly for the above-mentioned T-independor with and without anti-IFN-γ mAb (18). In contrast, IFN-γ deficiency would critically influence α-GalCer-stimulated IL-12 ent (bacterial stimulation) pathway. Because CD40L-expressing CHO cells can directly stimulate DC/macrophages production but can be restored by addition of rIFN-γ. Contrary to α-GalCer, CD40L-CHO cells also stimulate macrophages for IL-12 production in the absence of exogenous IFN-γ (26,31), IFN-γ has been regarded to be not an absolute that may not produce IFN-γ. In this case, addition of rIFN-γ may enhance IL-12 production even in wild-type splenocyte requirement for IL-12 production in the CD40L-stimulation pathway. This was confirmed in a recent paper (47). Neverthecultures. It is also possible that this type of stimulation, which is much stronger than α-GalCer stimulation, induces some less, the requirement for IFN-γ in IL-12 production in the two pathways appears to be more complicated as below levels of IL-12 production even in IFN-γ deficiency. Further studies will be required to investigate the mechanism by discussed.
Heinzel et al. examined whether IFN-γ deficiency alters the which the presence of IFN-γ or IFN-γ pre-exposure promotes the CD40L-mediated IL-12 production. in vivo IL-12 production occurring in the mouse model of acute endotoxemia (48). Their results showed that IFN-γ -/-Because the relative amounts of IL-12 and IL-4 influence the balance of T h 1/T h 2 differentiation, it would be critical how mice produced as much IL-12 p70 as wild-type mice did following injection with LPS, indicating that IFN-γ is not each of these cytokines is produced and which amount of each is produced. The present results illustrate that IFN-γ required for IL-12 production in the bacterial (LPS) stimulation pathway. This apparently contrasts with the well-accepted deficiency alters CD40L-stimulated IL-12 production particularly in the innate immune system involving the activation view of IFN-γ requirement in this pathway (19-21).
Contrary to the effect of IFN-γ on IL-12 production in the of V α 14 ϩ NKT cells. These results suggest that T h 1/T h 2 development is modulated in individuals with a reduced bacterial stimulation pathway, the present results demonstrated that the IFN-γ-deficient state fails to induce IL-12 IFN-γ-producing capacity. 
